Cefpodoxime Proxetil Tablets

This drug has strong antibacterial activity against Staphylococcus, Streptococcus, Pneumococcus, Peptostreptococcus, Gonorrhea, Branhamella catarrhalis, Escherichia coli, Klebsiella, Proteus (Proteus mirabilis, Proteus vulgaris, Providencia rettgeri, Providencia anomala), Citrobacter, Enterobacter, and Haemophilus influenzae.

The main ingredient of this product is cefpodoxime proxetil.

Respiratory tract infections, urinary and reproductive system infections, skin and soft tissue infections, otitis media, sinusitis, and mastitis.

Adults take 100 mg orally twice a day after meals. The dosage should be increased or decreased according to age and symptoms. In severe cases or ineffective cases, it can be increased to 200 mg/time, twice a day, after meals.

1. Shock: Shock symptoms may occur occasionally, so please pay attention to observation. If discomfort, abnormal sensation in the mouth, wheezing, dizziness, urge to defecate, tinnitus, or sweating occur, the drug should be discontinued. 2. Allergies: If allergic symptoms such as rash, urticaria, erythema, itching, fever, swollen lymph nodes, and joint pain occur, the drug should be discontinued and appropriate treatment should be taken. 3. Blood: Eosinophilia, thrombocytopenia, and occasionally granulocytopenia may occur. In addition, other cephalosporin antibiotics have been reported to cause hemolytic anemia. 4. Liver: SGOT, SGPT, alkaline phosphatase, and LDH may increase. 5. Kidney: BUN and blood creatinine may increase occasionally. In addition, other cephalosporin antibiotics may occasionally cause severe renal damage such as acute renal failure. Regular examinations and observations should be conducted. If abnormalities occur, the drug should be discontinued and appropriate treatment should be taken. 6. Digestive tract: Severe enteritis with bloody stools, such as pseudomembranous colitis, may occur occasionally. If abdominal pain or frequent diarrhea occurs, the drug should be discontinued immediately and appropriate measures should be taken. In addition, nausea, vomiting, diarrhea, soft stools, stomach pain, abdominal pain, loss of appetite, and stomach discomfort may occur occasionally. 7. Respiratory tract: When using other cephalosporin antibiotics, interstitial pneumonia and PIE syndrome may occur occasionally, accompanied by fever, cough, dyspnea, abnormal chest X-ray, and eosinophilia. If such symptoms occur, the drug should be discontinued and treated with adrenal hormones. 8. Occasionally, stomatitis and candidiasis may occur. 9. Vitamin deficiency: Symptoms of vitamin K deficiency (such as hypoprothrombinemia and bleeding tendency) and vitamin B deficiency (such as glossitis, stomatitis, loss of appetite, and neuritis) may occur occasionally. 10. Others: Dizziness, headache, and edema may occur occasionally.

Patients with a history of shock due to the ingredients of this drug.

When used in combination with antacids (such as aluminum hydroxide) or H2 receptor antagonists (such as ranitidine), the plasma concentration and drug absorption of CPDX can be reduced after taking CPDX-PR because gastric acid is neutralized.

Seal and store below 25℃.

0.1 g

24 months